吡拉西坦注射液辅助治疗急性脑卒中的临床效果观察.docVIP

吡拉西坦注射液辅助治疗急性脑卒中的临床效果观察 　　[摘要] 目的 观察吡拉西坦注射液对急性脑卒中患者进行辅助治疗的临床效果。 方法 选取嵊州市人民医院急性脑卒中患者36例，将其随机分为两组。对照组患者接受常规疗法，即脑细胞和营养神经细胞保护治疗以及脱水治疗等。治疗组患者在此基础上接受吡拉西坦注射液治疗。设置参照方法且限定参照条件后对患者的临床恢复状况进行比较性分析，观察且记录其效果。 结果 经过3周的治疗之后，治疗组基本痊愈7例，显著进步5例，进步3例，无效3例，无患者恶化，总有效率为83.33%，ADL评分为（73.72±13.33）分。对照组基本痊愈4例，显著进步4例，进步4例，无效3例，另有3例恶化，总有效率为66.67%，ADL评分为（65.63±4.48）分。两组总有效率和ADL评分比较差异有统计学意义（P 0.05）。 结论 经长期观察与严密对比，吡拉西坦注射液辅助治疗急性脑卒中能够取得很好的临床效果，可有效帮助患者恢复健康。此方法不仅可明显缩短住院时间，而且可以提高临床疗效，降低继发性并发症的发生率。故该疗法有很高的临床诊疗价值，适合推广施行。 　　[关键词] 急性脑卒中；吡拉西坦注射液；疗效 　　[中图分类号] R743.3 [文献标识码] A [文章编号] 1673-7210（2013）11（c）-0093-03 　　Clinical observation on the therapeutic effects of Piracetam Injection in treating acute cerebral apoplexy patients adjuvant 　　CHEN Lifang1 YANG Jie2 　　1.Shengzhou Peoples Hospital， Zhejiang Province， Shengzhou 312400， China； 2.Nanjing Medical University， Jiangsu Province， Nanjing 210029， China 　　[Abstract] Objective To observe the therapeutic effect of Piracetam Injection in treating acute cerebral apoplexy patients adjuvant. Methods 36 cases of acute cerebral patients in Shengzhou Peoples Hospital were divided into treatment group and control group. Patients in the treatment group were given the treatment of Piracetam Injection based on traditional treatments. Patients in the control group were given the general treatments including dehydration treatment， protection of nutritious nerve cells and brain cells. The patients manifestations of recovery condition were compared and analyzed through the way of restricting reference conditions and setting contrast， the effects were observed and recorded. Results After three weeks of treatment， in treatment group， the number of basic heal was 7 cases， remarkable improvement was 5 cases， improvement was 3 cases， no effect was 3 cases and no one was deteriorate， the total effective rate was 83.33%， and the score of ADL was （73.72±13.33） points. In the control group， the number of basic heal was 4 cases， remarkable improvement was 4 cases， improvem